Literature DB >> 11349095

Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis.

C G Feng1, U Palendira, C Demangel, J M Spratt, A S Malin, W J Britton.   

Abstract

Sequential immunization with mycobacterial antigen Ag85B-expressing DNA and Mycobacterium bovis bacille Calmette-Guerin (BCG) was more effective than BCG immunization in protecting against Mycobacterium tuberculosis infection. Depletion of the CD8(+) T cells in the immunized mice impaired protection in their spleens, indicating that this improved efficacy was partially mediated by CD8(+) T cells.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11349095      PMCID： PMC98488          DOI： 10.1128/IAI.69.6.4174-4176.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  20 in total

Review 1.  Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.

Authors:  A J Ramsay; S J Kent; R A Strugnell; A Suhrbier; S A Thomson; I A Ramshaw
Journal:  Immunol Rev       Date:  1999-10       Impact factor: 12.988

Review 2.  Induction of CD8+ T cells using heterologous prime-boost immunisation strategies.

Authors:  J Schneider; S C Gilbert; C M Hannan; P Dégano; E Prieur; E G Sheu; M Plebanski; A V Hill
Journal:  Immunol Rev       Date:  1999-08       Impact factor: 12.988

3.  CD4+ and CD8+ T cells mediate adoptive immunity to aerosol infection of Mycobacterium bovis bacillus Calmette-Guérin.

Authors:  C G Feng; W J Britton
Journal:  J Infect Dis       Date:  2000-05-09       Impact factor: 5.226

Review 4.  From naive to memory T cells.

Authors:  S L Swain; M Croft; C Dubey; L Haynes; P Rogers; X Zhang; L M Bradley
Journal:  Immunol Rev       Date:  1996-04       Impact factor: 12.988

5.  Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells.

Authors:  I Müller; S P Cobbold; H Waldmann; S H Kaufmann
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

6.  Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex.

Authors:  E Lozes; K Huygen; J Content; O Denis; D L Montgomery; A M Yawman; P Vandenbussche; J P Van Vooren; A Drowart; J B Ulmer; M A Liu
Journal:  Vaccine       Date:  1997-06       Impact factor: 3.641

7.  Specificity of CD8+ T cells from subunit-vaccinated and infected H-2b mice recognizing the 38 kDa antigen of Mycobacterium tuberculosis.

Authors:  X Zhu; H J Stauss; J Ivanyi; H M Vordermeier
Journal:  Int Immunol       Date:  1997-11       Impact factor: 4.823

8.  CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis.

Authors:  B L Freidag; G B Melton; F Collins; D M Klinman; A Cheever; L Stobie; W Suen; R A Seder
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

9.  Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.

Authors:  C H Ladel; S Daugelat; S H Kaufmann
Journal:  Eur J Immunol       Date:  1995-02       Impact factor: 5.532

10.  Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature.

Authors:  G A Colditz; T F Brewer; C S Berkey; M E Wilson; E Burdick; H V Fineberg; F Mosteller
Journal:  JAMA       Date:  1994-03-02       Impact factor: 56.272
View more
  36 in total

1.  Comparative protective effects of recombinant DNA and Mycobacterium bovis bacille Calmette-Guérin vaccines against M. avium infection.

Authors:  E Martin; J A Triccas; A T Kamath; N Winter; W J Britton
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

Review 2.  On the use of DNA vaccines for the prophylaxis of mycobacterial diseases.

Authors:  Kris Huygen
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

3.  Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis.

Authors:  Michael Santosuosso; Sarah McCormick; Xizhong Zhang; Anna Zganiacz; Zhou Xing
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

4.  Enhancing the protective efficacy of Mycobacterium bovis BCG vaccination against tuberculosis by boosting with the Mycobacterium tuberculosis major secretory protein.

Authors:  Marcus A Horwitz; Günter Harth; Barbara Jane Dillon; Sasa Maslesa-Galic
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection.

Authors:  Ming Zhang; Chunsheng Dong; Sidong Xiong
Journal:  Hum Vaccin Immunother       Date:  2016-12-14       Impact factor: 3.452

6.  Induction of Specific CD8 T Cells against Intracellular Bacteria by CD8 T-Cell-Oriented Immunization Approaches.

Authors:  Toshi Nagata; Yukio Koide
Journal:  J Biomed Biotechnol       Date:  2010-05-24

7.  Assessment of immune response to repeat stimulation with BCG vaccine using in vitro PBMC model.

Authors:  Rajpal S Kashyap; Aliabbas A Husain; Shweta H Morey; Milind S Panchbhai; Poonam S Deshpande; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  J Immune Based Ther Vaccines       Date:  2010-05-28

8.  Accelerated induction of mycobacterial antigen-specific CD8+ T cells in the Mycobacterium tuberculosis-infected lung by subcutaneous vaccination with Mycobacterium bovis bacille Calmette-Guérin.

Authors:  Dilara Begum; Masayuki Umemura; Ayano Yahagi; Yuko Okamoto; Satoru Hamada; Kiyotetsu Oshiro; Goro Matsuzaki
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

9.  Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin.

Authors:  H Martin Vordermeier; Shelley G Rhodes; Gillian Dean; Nilu Goonetilleke; Kris Huygen; Adrian V S Hill; R Glyn Hewinson; Sarah C Gilbert
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

10.  Ag85B DNA vaccine suppresses airway inflammation in a murine model of asthma.

Authors:  Jian Wu; Jun Xu; Chuang Cai; Xinglin Gao; Li Li; Nanshan Zhong
Journal:  Respir Res       Date:  2009-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.